Pinealon
Pinealon (Glu-Asp-Arg tripeptide)
Russian neuroprotective sleep tripeptide
About
Pinealon is a synthetic Glu-Asp-Arg (EDR) tripeptide from the Khavinson bioregulator family, developed at the St. Petersburg Institute of Bioregulation and Gerontology. It is proposed to enter cells and cross the nuclear membrane to bind gene promoter regions, influencing antioxidant and neurotrophic gene expression. The evidence base is dominated by Russian-language preclinical work and small clinical cohorts.
Mechanism
Proposed epigenetic regulation via direct binding to DNA promoter regions, modulating ERK 1/2 signaling and upregulating antioxidant and anti-apoptotic gene expression in neurons.
Dosage
Draw to 15 units on a U-100 insulin syringe
20 mg · 3 mL BAC
When to take: Morning or early afternoon. Most subjective changes appear after 10-14 days of daily use.
Reconstitution
Vial size (mg): 20 mg · BAC water (mL): 3 mL · Concentration: ~6.67 mg/mL
1 unit on a U-100 syringe ≈ 66.7 mcg; swirl gently, do not shake. Oral capsule form also exists.
Benefits
- Reported reduction of reactive oxygen species in neural cells
- Restoration of dendritic spines in Alzheimer's animal models
- Improvements in memory and mental clarity in small TBI cohorts
- Reported sleep quality improvements (often first noticeable effect)
- Possible mood and stress-resilience effects
Side effects
- Mild headache early in cycle
- Vivid dreams or altered sleep depth
- Mild GI effects (oral route)
- Injection-site redness or itching
- Long-term safety unmapped in Western trials
Gender notes
Cautions
- Pregnancy and breastfeeding
- Active or recent cancer history
- Seizure disorders
- Children and adolescents
- Concurrent CNS prescription medications
- Known peptide allergies
Research
- Neuroprotective Effects of Tripeptides — Epigenetic Regulators in Mouse Model of Alzheimer's Disease
Pharmaceuticals (MDPI) · 2021
EDR tripeptide treatment restored dendritic spine density (~71% increase) and reduced amyloid-beta toxicity markers in transgenic Alzheimer's mouse models.
- EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease
International Journal of Molecular Sciences · 2020
Khavinson group review proposing the mechanism by which Pinealon enters the nucleus and binds promoter regions to modulate antioxidant and neurotrophic gene expression.
- Peptide regulation of cell differentiation, gene expression and protein synthesis
Bulletin of Experimental Biology and Medicine · 2014
Khavinson review of short peptide bioregulators (including Pinealon) and their proposed mechanisms in aging and CNS function, summarizing decades of Russian preclinical data.